"In order to be a leader in the medicinal marijuana space, you need a high-quality product grown in a lab with serious controls. And ABcann is a leader when it comes to medical grade marijuana. So much so, in fact, that it has attracted the attention of Israel-based Syqe Medical (Syqe), which has been testing ABcann’s product for potential inclusion in its innovative inhaler device due to the consistency of ABcann’s products. This is important because Syqe isn’t just a small start-up – it’s a Company that has already partnered with not only the world’s biggest maker of generic drugs but also has investment from one of the world’s largest tobacco groups."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.